94 related articles for article (PubMed ID: 9722396)
1. Panniculitis associated with subcutaneous apomorphine.
Acland KM; Leslie T; Dowd PM
Hosp Med; 1998 May; 59(5):413-4. PubMed ID: 9722396
[No Abstract] [Full Text] [Related]
2. Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
Pot C; Oppliger R; Castillo V; Coeytaux A; Hauser C; Burkhard PR
Neurology; 2005 Jan; 64(2):392-3. PubMed ID: 15668455
[No Abstract] [Full Text] [Related]
3. Panniculitis in association with apomorphine infusion.
Acland KM; Churchyard A; Fletcher CL; Turner K; Lees A; Dowd PM
Br J Dermatol; 1998 Mar; 138(3):480-2. PubMed ID: 9580803
[TBL] [Abstract][Full Text] [Related]
4. Sleep attacks with apomorphine.
Homann CN; Suppan K; Wenzel K; Ivanic G; Kriechbaum N; Ott E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):430-1. PubMed ID: 12708100
[No Abstract] [Full Text] [Related]
5. Allergic contact dermatitis caused by apomorphine hydrochloride in a carer.
Garcia-Gavin J; González-Vilas D; Fernández-Redondo V; Campano L; Toribio J
Contact Dermatitis; 2010 Aug; 63(2):112-5. PubMed ID: 20629679
[No Abstract] [Full Text] [Related]
6. Recurrent atrial fibrillation after subcutaneous apomorphine.
Ardolino G; D'Adda E; Nobile-Orazio E
Parkinsonism Relat Disord; 2008; 14(2):173-4; author reply 175. PubMed ID: 17632031
[No Abstract] [Full Text] [Related]
7. The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study.
van Laar T; van Hilten B; Neef C; Rutgers AW; Pavel S; Bruijn JA
Mov Disord; 1998 Jan; 13(1):52-5. PubMed ID: 9452326
[TBL] [Abstract][Full Text] [Related]
8. Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease.
LeWitt PA; Ondo WG; Van Lunen B; Bottini PB
Clin Neuropharmacol; 2009; 32(2):89-93. PubMed ID: 18978491
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
Wenning GK; Bösch S; Luginger E; Wagner M; Poewe W
Adv Neurol; 1999; 80():545-8. PubMed ID: 10410769
[No Abstract] [Full Text] [Related]
10. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
Manson AJ; Turner K; Lees AJ
Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
[TBL] [Abstract][Full Text] [Related]
11. Apomorphine-induced necrotic ulcers.
Ganesalingam J; Bain P
Mov Disord; 2011 Oct; 26(12):2182. PubMed ID: 21956252
[No Abstract] [Full Text] [Related]
12. Immediate type 1 hypersensitivity to apomorphine: a case report.
Gutiérrez D; Foncubierta A; Espinosa R; Astorga S; Leon A; Fernández S
J Investig Allergol Clin Immunol; 2011; 21(4):325-6. PubMed ID: 21721386
[No Abstract] [Full Text] [Related]
13. Dapsone dependent nodular panniculitis.
Uplekar MW; Antia NH
Indian J Lepr; 1986; 58(2):286-90. PubMed ID: 3805799
[TBL] [Abstract][Full Text] [Related]
14. [Corticosteroid-induced panniculitis].
Plechistova LA
Vestn Dermatol Venerol; 1978 Feb; (2):50-2. PubMed ID: 636589
[No Abstract] [Full Text] [Related]
15. Use of apomorphine in clinical practice.
MacMahon DG
Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
[No Abstract] [Full Text] [Related]
16. Povidone panniculitis. Polyvinylpyrrolidone panniculitis.
Kossard S; Ecker RI; Dicken CH
Arch Dermatol; 1980 Jun; 116(6):704-6. PubMed ID: 7377808
[TBL] [Abstract][Full Text] [Related]
17. [Unusual complication of steroid treatment in the child: panniculitis].
Stoll C; Stein S; Strobel M; Grosshans E; Lévy JM
Pediatrie; 1974 Sep; 29(6):635-9. PubMed ID: 4533066
[No Abstract] [Full Text] [Related]
18. Necrotic Ulcers Secondary to Apomorphine Infusion.
Llamas-Osorio Y; McLoughlin C; Maguire M; Lynch T
Tremor Other Hyperkinet Mov (N Y); 2021; 11():55. PubMed ID: 35070491
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose.
Pahwa R; Koller WC; Trosch RM; Sherry JH;
J Neurol Sci; 2007 Jul; 258(1-2):137-43. PubMed ID: 17466338
[TBL] [Abstract][Full Text] [Related]
20. [Posteroid panniculitis (author's transl)].
Mau G
Klin Padiatr; 1973 May; 185(3):222-4. PubMed ID: 4795576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
